bioMérieux SA

A world leader in the field of in vitro diagnostics since 1963, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2022, revenues reached €3.6 billion, with over 90% of sales outside of France.

bioMérieux provides diagnostic solutions (systems, reagents, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

Role in the project: Within WP4, bioMérieux will support food manufacturers in two different ways to better estimate the actual shelf-life of their products. We will be developing rapid, molecular diagnostic assays for the early detection of spoilage organisms in chicken and salmon to help food industries take corrective action in an earlier stage. Additionally, we will support the University of Denmark with our data modeling expertise in the generation of digital twins for chicken and salmon food items which will allow a more accurate prediction of the shelf-life of these products.